<DOC>
	<DOCNO>NCT00543686</DOCNO>
	<brief_summary>Explorative comparison montelukast inhaled steroid ( fluticasone ) estimate responder profile , term symptom score , rescue medication , increase FEV1 , correlation presence allergy , bronchial hyperreactivity ( PD20 ) , exhale NO , excretion leukotrienes , response RABA laboratory parameter patient pre-school asthma i.e . asthma phenotype .</brief_summary>
	<brief_title>Leukotriene Receptor Antagonists Steroids Pre-School Asthma</brief_title>
	<detailed_description />
	<mesh_term>Asthma</mesh_term>
	<mesh_term>Leukotriene Antagonists</mesh_term>
	<mesh_term>Montelukast</mesh_term>
	<mesh_term>Fluticasone</mesh_term>
	<criteria>Male female patient age 4 6 year Diagnosis mild intermittent bronchial asthma ( Step III ) past 6 12 month state investigator : Use inhale beta2agonists &lt; 1/week ( max 3 puff /d ) Exacerbationfree interval &gt; 4 week prior visit 1 The write informed consent parent receive write oral information aim , purpose risk study must present Asthma severity â‰¥ Step 2 Severe concomitant disease Suspected noncompliance age 4 age 7 year last study participation &lt; 30 day</criteria>
	<gender>All</gender>
	<minimum_age>4 Years</minimum_age>
	<maximum_age>6 Years</maximum_age>
	<verification_date>February 2009</verification_date>
	<keyword>Pre-School Asthma</keyword>
	<keyword>Responder Profiles</keyword>
	<keyword>Fluticasone</keyword>
	<keyword>Montelukast</keyword>
	<keyword>Leukotriene</keyword>
	<keyword>Children Pre-School Asthma</keyword>
</DOC>